Blood ASH 96/2 treatment with BMT, and serial samples were analyzed for levels of
genomic and mRNA BCR-ABL using DNA-PCR with patientspecific primers and RT-PCR …

A modified two-step polymerase chain reaction (PCR) was used for the amplification of
BCR/ABL mRNA in 16 patients with Philadelphia chromosomepositive (Ph+) chronic …

In chronic myelogenous leukemia (CML), amplification of a segment of bcr-abl messenger
RNA (mRNA) by polymerase chain reaction (PCR) can be used to detect minimal residual …

We have utilized the polymerase chain reaction (PCR) to sensitively detect persistence of
the chronic myelogenous leukemia (CML) malignant clone and to study bcr/abl mRNA …

We identified 243 patients with Philadelphia (Ph) chromosome–positive chronic myeloid
leukemia (CML) who had BCR-ABL transcripts monitored by quantitative reverse …

AUogeneic bone marrow transplantation (BMT) is considered to be the only curative therapy
for chronic myelogenous leukemia (CML). The cytogenetic marker of CML, the Philadelphia …

The bcr-abl RNA transcript is the molecular counterpart of the Philadelphia chromosome
and is detectable by an extremely sensitive polymerase chain reaction assay in most …

We studied 346 patients after bone marrow transplantation (BMT) for chronic myeloid
leukemia (CML) for the presence of the bcr-abl transcript detected by the polymerase chain …

Although serial detection of bcr-abl positive cells by PCR appears able to identify distinct
patient groups with different risks of relapse following BMT, there remain many unanswered …

We report here the results of polymerase chain reaction (PCR) for bcr-abl transcript and
clinical details derived from 64 chronic myelogenous leukemia (CML) patients after …